Pharmacokinetic (PK) - pharmacodynamic (PD) study of gemcitabine (G) in a randomised phase II trial of carboplatin (C) combined with G at standard rate infusion or fixed dose rate infusion in patients with advanced non-small-cell lung cancer (NSCLC).

被引：0
|
作者：
Soo, RA
Lim, HL
Wang, LZ
Tham, LS
Soong, R
Lee, HS
Liang, S
Lee, SC
Boyer, M
Goh, BC
机构：
[1] Natl Univ Singapore Hosp, Singapore 117548, Singapore
[2] Natl Univ Singapore, Singapore 117548, Singapore
[3] Clin Trials & Epidemiol Res Unit, Singapore, Singapore
[4] Sydney Canc Ctr, Sydney, NSW, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：141S / 141S
页数：1
相关论文
共 50 条
  • [21] Phase II trial of a 2-h infusion of gemcitabine plus carboplatin as first-line chemotherapy for advanced non-small-cell lung cancer
    N. Xu
    P. Shen
    X. C. Zhang
    L. F. Yu
    H. Y. Bao
    G. M. Shi
    S. Huang
    J. Chen
    H. B. Mou
    W. J. Fang
    Cancer Chemotherapy and Pharmacology, 2007, 59 : 1 - 7
  • [22] A phase II trial of pemetrexed (P) plus carboplatin (C) in patients (pts) with advanced non-small-cell lung cancer (NSCLC).
    Koshy, S
    Herbst, RS
    Obasaju, CK
    Fossella, F
    Papadimitrakopoulou, V
    Pisters, KMW
    Blumenschein, G
    Peeples, BO
    Hong, WK
    Zinner, RG
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 634S - 634S
  • [23] Treatment with paclitaxel 1-h infusion and carboplatin of patients with advanced non-small-cell lung cancer:: a phase II multicentre trial
    Helsing, M
    Thaning, L
    Sederholm, C
    Lamberg, K
    Martinsson, JE
    Ek, L
    Månsson, T
    Andersson, L
    Hero, U
    Anjedani, D
    Svennson, G
    LUNG CANCER, 1999, 24 (02) : 107 - 113
  • [24] A phase II study of carboplatin plus gemcitabine in advanced non-small-cell lung cancer (NSCLC) - A hoosier oncology group study
    Ng, EW
    Sandler, AB
    Robinson, L
    Einhorn, LH
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (06): : 550 - 553
  • [25] Multicenter phase H trial of biweekly carboplatin and gemcitabine for untreated advanced non-small-cell lung cancer (NSCLC)
    Dómine, M
    Gómez, RG
    Firvida, JL
    Delgado, JR
    Estévez, LG
    León, A
    Casado, V
    Alvarez, R
    Alfonso, AL
    Lobo, F
    ANNALS OF ONCOLOGY, 2005, 16 : 308 - 308
  • [26] Gemcitabine administered as a short infusion versus a fixed dose rate in combination with cisplatin for the treatment of patients with advanced non-small cell lung cancer
    Pereira, Jose R.
    Fein, Luis
    del Giglio, Auro
    Blajman, Cesar R.
    Richardet, Eduardo
    Schwartsmann, Gilberto
    Orlando, Mauro
    Hall, Belinda J.
    West, Teena M.
    van Kooten, Maximiliano
    LUNG CANCER, 2007, 58 (01) : 80 - 87
  • [27] Phase II pharmacodynamic trial of erlotinib in previously treated patients with advanced non-small-cell lung cancer (NSCLC):: Study results
    Felip, Enriqueta
    Rojo, Frederico
    Reck, Martin
    Heller, Astrid
    Klughammer, Barbara
    Maacke, Heiko
    Mocks, Joachim
    Brennscheidt, Ulrich
    Gatzemeier, Ulrich
    Baselga, Jose
    ANNALS OF ONCOLOGY, 2006, 17 : 235 - 235
  • [28] Fixed dose rate infusion of gemcitabine with oral doxifluridine and leucovorin for advanced unresectable pancreatic cancer: A phase II study
    Kim, Hawk
    Park, Jae-Hoo
    Shin, Su Jin
    Kim, Mee-Ja
    Bang, Sung-Jo
    Park, Neung Hwa
    Nah, Yang Won
    Nam, Chang Woo
    Joo, Kwang Ro
    Min, Young Joo
    CHEMOTHERAPY, 2008, 54 (01) : 54 - 62
  • [29] Low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small-cell lung cancer: a phase I and II trials
    Zwitter, M
    Kovac, V
    Smrdel, U
    Kocijancic, I
    LUNG CANCER, 2004, 45 : S77 - S78
  • [30] Paclitaxel and carboplatin in combination with gemcitabine: A phase I-II trial in patients with advanced non-small-cell lung cancer
    Favaretto, A
    Ceresoli, GL
    Paccagnella, A
    Barbieri, F
    Bearz, A
    Ghiotto, C
    Oniga, F
    Schiavon, S
    Frustaci, S
    Villa, E
    ANNALS OF ONCOLOGY, 2000, 11 (11) : 1421 - 1426
12345